UBS Group’s Calamos Convertible Equity Alternative ETF CVRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360 Buy
+7
New +$346 ﹤0.01% 9899
2025
Q4
Sell
-25
Closed -$908 10605
2025
Q3
$908 Sell
25
-1,205
-98% -$41K ﹤0.01% 9498
2025
Q2
$39.4K Buy
1,230
+77
+7% +$2.29K ﹤0.01% 7968
2025
Q1
$33K Buy
1,153
+867
+303% +$26.2K ﹤0.01% 7880
2024
Q4
$8.58K Buy
+286
New +$8.68K ﹤0.01% 8398
2024
Q3
Sell
-40
Closed -$1.08K 9576
2024
Q2
$1.08K Buy
+40
New +$1.08K ﹤0.01% 8660
2024
Q1
Sell
-118
Closed -$3.18K 9413
2023
Q4
$3.18K Buy
+118
New +$2.94K ﹤0.01% 8003

Other funds holding CVRT

UBS Group's CVRT Position: Q2 2026 in Review

UBS Group opened a new position in Calamos Convertible Equity Alternative ETF (CVRT) in Q2 2026: 7 shares worth $360. The stake represents ﹤0.01% of the portfolio and ranks #9899 among its holdings. This is a return to the name: UBS Group previously reported a position in CVRT as recently as Q3 2025.

UBS Group first reported a position in CVRT in Q4 2023 and has held it in 7 quarters since. The position peaked at $39.4K in Q2 2025. 18 funds tracked by Wall St. Rank hold CVRT as of Q2 2026.

  • UBS Group held 7 shares of Calamos Convertible Equity Alternative ETF worth $360 as of Q2 2026.
  • Calamos Convertible Equity Alternative ETF was a new UBS Group position in Q2 2026.
  • Calamos Convertible Equity Alternative ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9899 holding.
  • UBS Group first reported a position in Calamos Convertible Equity Alternative ETF in Q4 2023 and has held it in 7 quarters since.
  • UBS Group's Calamos Convertible Equity Alternative ETF position peaked at $39.4K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Calamos Convertible Equity Alternative ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.